Mylan's Copaxone Suit Against Teva Should Survive, Judge Says
Teva Pharmaceutical Industries Ltd.'s bid to dismiss antitrust claims should be denied in a case where Mylan Pharmaceuticals Inc. alleges the company unlawfully delayed a generic version of a multiple ...
TMDX STOCK NEWS: TransMedics Group, Inc. Investors are Reminded to Contact BFA Law about the Pending Class Action before the April 15 Deadline
New York, New York-- (Newsfile Corp. - March 1, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX) ...
SMTC STOCK NEWS: Semtech Corp. Investors are Reminded to Contact BFA Law about the Pending Class Action before the April 22 Deadline
New York, New York-- (Newsfile Corp. - March 1, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Semtech Corp. (NASDAQ: SMTC) and certain ...
Ugly shoes can keep hitting their stride
Ugly shoes had a good 2023 and an even better 2024. Yet after a blistering run, they appear to be losing their stride. Shares ...
Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds
Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH) reported fourth-quarter adjusted EPS of 92 cents, up from 88 cents a year ago, ...
S&P 500 February winners, losers as stock benchmark ends monthly journey in the red
The S&P 500 (SP500) hit new highs during February trade, but that wasn’t enough to stave off a monthly loss.  The benchmark ...
PharmiWeb13h
Global Generic Oncology Drugs Market Poised for Steady Growth, Projected to Reach USD 30,606.3 Million by 2035
The global generic oncology drugs market is set for consistent growth over the next decade, with sales anticipated to rise from USD 23,743.5 million in 2025 to USD 30,606.3 million by 2035, reflecting ...